Beagle Bio Tech
Latest round
- Series A
Last raised
- Mar 2020
Total raised
- Undisclosed
Investors
- 1
About Beagle Bio Tech
Established in 2018 and based in Changzhou, China, Beagle Bio Tech is a biotechnology company that focuses on the research and development of exosome technology. The company's main products are exosome enrichment and extraction and analysis platforms for contained biomarkers. Its products are used in Alzheimer's and Parkinson's diseases.
Who invested in Beagle Bio Tech
1 investor across 1 round
See all investors in Beagle Bio Tech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 1, 2020
Amount
Undisclosed
Investors
Questions about Beagle Bio Tech
Who invested in Beagle Bio Tech?
Beagle Bio Tech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beagle Bio Tech raised?
Beagle Bio Tech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beagle Bio Tech last raise money?
Beagle Bio Tech's most recent round on record is a Series A, in Mar 2020.
What does Beagle Bio Tech do?
Established in 2018 and based in Changzhou, China, Beagle Bio Tech is a biotechnology company that focuses on the research and development of exosome technology.
Where is Beagle Bio Tech headquartered?
Beagle Bio Tech is headquartered in Changzhou, China.
Which VCs invest in companies like Beagle Bio Tech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beagle Bio Tech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beagle Bio Tech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.